Rapamycin Therapy at Longevity Clinics (2026)
Rapamycin (sirolimus) is a prescription medicine first developed as an immunosuppressant and approved for uses such as preventing organ transplant rejection. Some longevity physicians prescribe it off-label in lower or intermittent regimens because it acts on a nutrient-sensing pathway strongly associated with aging biology. Rapamycin is not approved as an anti-aging treatment, and no human trial has shown that it extends lifespan in healthy people.
How Rapamycin Therapy Works
Rapamycin inhibits the mechanistic target of rapamycin (mTOR), particularly mTOR complex 1, a pathway that coordinates cell growth, protein synthesis, metabolism, and responses to nutrients. Reducing mTORC1 activity can shift cells away from growth signals and toward maintenance processes such as autophagy. This mechanism has extended lifespan in multiple animal models, but the balance between a potentially useful intermittent effect and clinically significant immune, metabolic, or healing effects has not been established for healthy human aging.
Scientific Evidence
Animal evidence for rapamycin is unusually strong, while human longevity evidence remains preliminary. A 2024 systematic review in The Lancet Healthy Longevity found promising signals from rapamycin and related compounds, but most human studies were small, short, or focused on particular diseases rather than aging outcomes. A National Institute on Aging-funded UT Health San Antonio study is testing pharmacokinetics, daily versus intermittent schedules, biomarkers, and safety in older adults. These trials may improve dosing knowledge, but current evidence does not establish lifespan extension or a standard preventive protocol.
Pricing Overview
Pricing varies because rapamycin for longevity is an off-label prescription rather than a standardized clinic procedure. The medication, medical consultation, laboratory screening, follow-up, and any therapeutic drug monitoring may be billed separately. Ask for a written quote and clarify which baseline and repeat tests are included. A lower drug price does not remove the need for physician review of infection risk, blood counts, lipids, glucose, liver and kidney function, wound healing, and medication interactions.
Clinic Availability
We are currently auditing which clinics in our directory offer Rapamycin Therapy. Check individual clinic profiles or browse all clinics to find providers.
Frequently Asked Questions
Common questions about Rapamycin Therapy at longevity clinics.
Is rapamycin approved for anti-aging or longevity?
No. Rapamycin is an approved prescription medicine for specific medical indications, but regulators have not approved it to slow aging or extend lifespan. Longevity prescribing is off-label and should not be presented as a proven preventive treatment.
Does rapamycin extend human lifespan?
That has not been demonstrated. Rapamycin extends lifespan in several animal models, and early human studies have examined immune function and other biomarkers, but there is no completed human trial showing longer life in healthy people.
Why do longevity clinics use intermittent rapamycin?
Some clinicians use intermittent schedules in an attempt to affect mTORC1 while limiting sustained immunosuppression and other adverse effects. The optimal dose, interval, target biomarker, and long-term safety profile for generally healthy adults remain unsettled, so a popular protocol is not the same as a validated standard.
What should a clinic monitor during rapamycin therapy?
A prescribing clinician may consider baseline health, current medicines, infection risk, blood counts, lipids, glucose, liver and kidney function, oral symptoms, wound healing, and adverse effects. The exact plan must be individualized, and patients should receive explicit stop rules and a route to report problems.
Can I use rapamycin without medical supervision?
Self-medication is unsafe. Rapamycin has clinically important adverse effects and interactions, and it can affect immune function, metabolism, blood counts, oral health, and wound healing. A qualified prescriber should determine whether there is any defensible indication and monitor treatment.